RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene therapies to genome editing and synthetic biology. However, designing RNA ...
Biohub researchers performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then ...
The rapid development of China's RAS-targeted cancer drugs could reshape global oncology and unlock the country's undervalued ...
Biohub researchers performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine ...
BioCompute expands funding to innovate DNA data storage, aiming for efficient, sustainable long-term archival solutions for ...
As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ...
Kogi State Governor Ahmed Usman Ododo, FCA, has called on young people in the state to support the administration of Bola ...
Rekor Systems, Inc. (NASDAQ: REKR) ("Rekor" or the "Company"), a technology company developing trusted-data, privacy, security, and intelligence solutions for real-world transportation, public-safety, ...
Lantern Pharma Inc. , a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI co-scientist platform, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results